Chronic Migraines and Neurofdeeback Mindfulness
ConditionChronic Migraine, Headache
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Saskatchewan
About this trial
As the second phase of our study on migraine headaches and neurofeedback mindfulness, we will explore how chronic migraineurs will benefit from a long term practice (8 weeks) of neurofeedback mindfulness compared to a similar attention group and a waitlisted group. This randomized controlled trial will also explore if migrianuers could decrease their dependence on medicine intake after completion of the study.
Eligibility criteria
Qualifiers
have a diagnosis of chronic migraine from a clinician or have met the criteria for a chronic migraine diagnosis based on ICHD-3
reside in Saskatoon area
have a smartphone and internet connection for accessing the MUSE app
have no frequent background experience of meditation
Disqualifiers
Comorbidity of Raynaud's syndrome or diabetes
Current use of a preventative migraine treatment over 6 months
Trial design
Treatments tested in this trial
- Neurofeedback Mindfulness
- Attention Task
Treatment groups
135 Participants
are divided into 3 treatment groupsLocations
1University of SaskatchewanS7N5A2, SaskatoonSaskatchewan, Canada
Sponsors and collaborators
University of Saskatchewan
Lead sponsor
Saskatchewan Health Research Foundation
Collaborator
Source ClinicalTrials.gov